The Vietnamese Drug Registration Advisory Council has proposed that the Ministry of Health approve the importation of Pfizer COVID-19 vaccine.
The proposal followed a meeting convened by the council with the participation of experts on drugs, vaccines, and medical biological products on Monday.
The COVID-19 vaccine produced by American pharmaceutical giant Pfizer Inc. and its German partner BioNTech SE is one of the most sought-after COVID-19 vaccines in the world and is widely used in the U.S. and Europe.
Since early 2020, the Pfizer jab has been approved by the World Health Organization (WHO) for emergency use, based on its safety and immunogenicity records.
The Vietnamese Ministry of Health previously said that it had negotiated to buy 31 million doses of the Pfizer COVID-19 vaccine, with the first batch expected to arrive in Vietnam by July.
Once approved by the ministry, the Pfizer shot will become the fourth coronavirus vaccine to be imported into Vietnam, after the Anglo-Swedish AstraZeneca, Russia’s Sputnik V, and China’s Sinopharm.
Nearly 1.37 million coronavirus doses have been administered to people in Vietnam as of Tuesday, with more than 42,100 of them receiving two full shots.
The Ministry of Health confirmed 283 cases of COVID-19 at noon on Wednesday, including 201 infections that had been screened in northern Bac Giang Province between May 27 and 29 but were just numbered now.
The new cases took the national caseload to 9,505 patients, with 3,549 recoveries and 55 deaths.
As many as 6,328 domestic infections have been recorded in the country since April 27.